Fresenius Medical Care AG (FMS) Notes Payables (2009 - 2026)

Fresenius Medical Care AG's Notes Payables history runs 17 years deep, the most recent figure standing at $859.1 million for Q4 2025.

• In Q4 2025, Notes Payables fell 11.07% year-over-year to $859.1 million; the TTM figure through Dec 2025 stood at $859.1 million (down 11.07% YoY), while the FY2025 annual figure was $859.1 million, down 11.07% from the prior year.
• Notes Payables for Q4 2025 stood at $859.1 million, up from $848.6 million in the prior quarter.
• The five-year high for Notes Payables was $966.0 million in Q4 2024, with the low at $766.5 million in Q1 2021.
• The 5-year median for Notes Payables is $834.0 million (2021), against an average of $837.8 million.
• Peak annual rise in Notes Payables reached 132.29% in 2021, while the deepest fall reached 53.93% in 2021.
• Fresenius Medical Care AG's Notes Payables stood at $842.0 million in 2021, then retreated by 1.46% to $829.7 million in 2022, then declined by 1.19% to $819.9 million in 2023, then rose by 17.83% to $966.0 million in 2024, then slipped by 11.07% to $859.1 million in 2025.
• Business Quant data shows FMS's Notes Payables at $859.1 million in Q4 2025, $848.6 million in Q3 2025, and $775.6 million in Q2 2025.